Comparative Efficacy of Ceftriaxone in Experimental Infections Involving Bacteroides fragilis and Escherichia coii
- 1 January 1993
- journal article
- research article
- Published by S. Karger AG in Chemotherapy
- Vol. 39 (5) , 355-360
- https://doi.org/10.1159/000239147
Abstract
The in vivo activity of ceftriaxone was examined in an experimentally induced subcutaneous infection involving Bacteroides fragilis and Escherichia coli. Mice were challenged with 1 of 10 strains of B. fragilis or E. coli, or a dual combination of the two species. The efficacy was measured by a reduction in the count of viable organisms when antimicrobial treatment was initiated 1 h after challenge and continued for 5 days. Ceftriaxone exhibited impressive activity against E. coli but showed poor in vivo activity versus B. fragilis. The antimicrobial activity of ceftriaxone was influenced by the microbial interaction in our dual-isolate model. Pharmacokinetic studies showed that ceftriaxone penetrated into abscesses and achieved peak levels of about 40% of the peak serum levels. However, in abscesses infected with B. fragilis nearly all biological activity of ceftriaxone was lost.Keywords
This publication has 0 references indexed in Scilit: